Pancreatic adenocarcinoma tumor grade determination using contrast-enhanced magnetic resonance imaging

Thomas C Lauenstein1, Diego R Martin, Juan M Sarmiento

  • 1Department of Radiology, Emory University Hospital, Atlanta, GA, USA. Thomas.lauenstein@uni-due.de

Pancreas
|September 12, 2009
PubMed
Abstract

Insights

Arterial phase gadolinium-enhanced MRI shows enhancement patterns that correlate with the histological grade of pancreatic adenocarcinoma. This imaging technique can help assess tumor differentiation non-invasively.

Area of Science:

  • Radiology
  • Oncology
  • Pathology

Background:

  • Pancreatic adenocarcinoma is a challenging malignancy with variable differentiation.
  • Accurate assessment of tumor grade is crucial for prognosis and treatment planning.
  • Histopathological grading is the current standard but requires invasive biopsy.

Purpose of the Study:

  • To investigate the correlation between arterial phase enhancement on gadolinium-enhanced MRI and the histopathological grade of pancreatic adenocarcinoma.

Main Methods:

  • 39 patients with pancreatic adenocarcinoma underwent MRI prior to resection.
  • Arterial phase images were analyzed for enhancement patterns (low, moderate, high).
  • MRI enhancement patterns were compared with conventional histological grading.

Main Results:

  • Agreement between MRI enhancement and histological grade was observed in 30 out of 39 cases (Cohen's kappa = 0.64).
  • No significant difference in mean tumor size was found between groups.
  • Minor discordance was noted in 9 cases, but overall correlation was statistically significant.

Conclusions:

  • Arterial phase enhancement on gadolinium-enhanced MRI correlates with the histological grade of pancreatic adenocarcinoma.
  • MRI may offer a non-invasive method to assess tumor differentiation.

Related Concept Videos